New Breast Cancer Mechanism Found – Potential for Targeted Therapies

Aggressive breast cancers often spread more rapidly than others, and scientists are working to understand why. A latest study from Åbo Akademi University in Finland, published in Science Advances, suggests a key mechanism involving a protein called Jagged1 and its impact on the stiffness of tissue surrounding tumors. This discovery could open new avenues for treating particularly challenging forms of breast cancer where targeted therapies are currently limited.

The Role of Tissue Stiffness in Cancer Progression

For some time, researchers have known that the physical properties of the tissue surrounding a tumor – its stiffness, for example – can influence how quickly cancer cells spread. Tumors aren’t isolated entities; they interact with their environment, and changes in that environment can either promote or hinder cancer progression. This new research focuses on how a specific signaling pathway, the Jagged1-Notch pathway, contributes to this process. The Jagged1-Notch pathway is known to be important for cell communication and development, and previous work from Professor Cecilia Sahlgren’s lab at Åbo Akademi had already established its role in directing vessel growth and stability.

The team, led by Professor Sahlgren and including researchers Noora Virtanen, Kai-Lan Lin, Elmeri Kiviluoto, Oscar Stassen, and Freddy Suarez Rodriguez, discovered that the protein Myo1c plays a crucial role in this process. Myo1c is a molecular motor protein, meaning it physically moves things around inside cells. The study found that when cells experience shear stress – the force exerted by blood flow – Myo1c releases Jagged1. This release isn’t random; it’s a precisely controlled delivery system, ensuring that the Jagged1 signal reaches the right location within the cell at the right time.

How Jagged1 Impacts the Microenvironment

The release of Jagged1 appears to trigger a feedback loop that stiffens the tissue around the tumor. This increased stiffness, in turn, can promote further cancer cell growth and spread. Essentially, the tumor is altering its environment to develop it more hospitable for its own expansion. This is a significant finding because it identifies a specific molecular mechanism driving this process. Understanding this mechanism could lead to the development of drugs that disrupt the feedback loop, potentially slowing or stopping cancer progression.

What Does This Imply for Breast Cancer Treatment?

Currently, many aggressive forms of breast cancer lack targeted therapies – treatments designed to specifically attack cancer cells whereas leaving healthy cells relatively unharmed. Chemotherapy, while effective, often has significant side effects because it affects all rapidly dividing cells in the body, not just cancer cells. The discovery of the Jagged1-Myo1c pathway offers a potential new target for developing more precise therapies.

Still, it’s important to emphasize that this research is still in its early stages. The study was conducted primarily in laboratory settings, using cells grown in culture. Further research is needed to confirm these findings in animal models and, eventually, in human clinical trials. It’s likewise crucial to understand that breast cancer is a complex disease with many different subtypes, and this particular mechanism may not be relevant to all types of breast cancer.

The InFLAMES Flagship and Cardiovascular Research

This research is part of a larger effort by the InFLAMES Research Flagship, an innovation ecosystem based on the immune system at Åbo Akademi University. The InFLAMES flagship focuses on understanding how the immune system interacts with other systems in the body, including the cardiovascular system. Professor Sahlgren’s Cell Fate Lab investigates how mechanical forces and biological signaling pathways regulate cardiovascular tissue health and disease. This broader context highlights the importance of considering the interplay between different biological systems when studying complex diseases like cancer.

Study Details and Limitations

The study, published in Science Advances, involved detailed molecular analysis of endothelial cells – the cells that line blood vessels. Researchers used advanced imaging techniques to observe the movement of Myo1c and the release of Jagged1 in response to shear stress. While the findings are compelling, it’s important to acknowledge the limitations of this type of research. Cell culture studies don’t fully replicate the complexity of the human body. The interactions between cancer cells, immune cells, and the surrounding tissue are far more intricate in vivo (within a living organism) than they are in a petri dish.

the study focused on a specific aspect of cancer progression – the role of tissue stiffness. Other factors, such as genetic mutations, hormonal influences, and lifestyle factors, also play a significant role in determining how quickly a cancer spreads.

What Comes Next: From Lab to Clinic

The next steps in this research will involve testing these findings in animal models of breast cancer. Researchers will need to determine whether blocking the Jagged1-Myo1c pathway can effectively slow tumor growth and prevent metastasis (the spread of cancer to other parts of the body). If the results in animal models are promising, the researchers may then move on to clinical trials in humans.

Clinical trials are a multi-phase process, designed to evaluate the safety and efficacy of new treatments. Phase 1 trials typically involve a small number of patients and focus on safety. Phase 2 trials assess the treatment’s effectiveness and identify potential side effects. Phase 3 trials compare the new treatment to the current standard of care in a larger group of patients.

It’s important to remember that the development of new cancer treatments is a long and complex process. Even if this research leads to a promising new therapy, it could still be several years before it becomes available to patients. However, this discovery represents a significant step forward in our understanding of how breast cancer spreads and offers hope for the development of more effective treatments in the future.